OSTEOPORE LIMITED - Announcements

9.09%

1.0¢

Market Cap $2.372M

Healthcare Medical Devices

Osteopore Limited is a regenerative medicine company engaged in three-dimensional... Osteopore Limited is a regenerative medicine company engaged in three-dimensional (3D)-printed biomimetic and bioresorbable implants. The Company’s commercialized products are designed to enable natural bone healing across multiple therapeutic areas. The Company’s patented technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. Through its proprietary manufacturing process, which uses a naturally dissolving polymer, its patented scaffolds enable bone tissue growth, significantly reducing the post-surgery complications commonly associated with permanent bone implants. The Company’s surgical specialty includes craniotomy, orbital floor reconstruction, socket preservation, cranioplasty patient-specific implants (PSI), craniosynostosis, guided bone regeneration, endoscopic transsphenoidal skull base surgery, burr hole restoration with the shunt drainage system, mandible PSI, and immediate implant loading, among others.More

Announcements

Filter Results

All Price Sensitive Only

OSX	Results of Annual General Meeting		30/05/23	267.26KB	Share
OSX	Notification regarding unquoted securities - OSX		25/05/23	27.7KB	Share
OSX	Largest South African Medical Insurer provides cover for OSX	PRICE SENSITIVE	16/05/23	278.1KB	Share
OSX	Notification regarding unquoted securities - OSX		12/05/23	28.58KB	Share
OSX	Change of Registered Office		05/05/23	140.94KB	Share
OSX	Change of Director's Interest Notice - TSH		28/04/23	226.02KB	Share
OSX	Change of Director's Interest Notice - ML		28/04/23	224.21KB	Share
OSX	Notice of Annual General Meeting		28/04/23	615.69KB	Share
OSX	Activities Update Qtr Ending March 2023 and Appendix 4C	PRICE SENSITIVE	28/04/23	3.43MB	Share
OSX	OSX Successfully transitions to EU Medical Device Regulation	PRICE SENSITIVE	27/04/23	238.93KB	Share
OSX	Reinstatement of Security Class to Quotation	PRICE SENSITIVE	26/04/23	412.9KB	Share
OSX	Top 20 and Distribution List - Options		26/04/23	17.33KB	Share
OSX	Application for quotation of securities - OSX		24/04/23	25.08KB	Share
OSX	Application for quotation of securities - OSX		24/04/23	29.48KB	Share
OSX	Security Class Suspension from Quotation	PRICE SENSITIVE	24/04/23	416.22KB	Share
OSX	Non-Renounceable Entitlement Offer - Results	PRICE SENSITIVE	24/04/23	233.65KB	Share
OSX	Osteopore Increases Presence in Singapore Dental Market		14/04/23	247.63KB	Share
OSX	Osteopore to Commercialise Innovative Bone Rengeneration Tec		14/04/23	264.89KB	Share
OSX	Employee Securities Incentive Plan		13/04/23	370.57KB	Share
OSX	Non-Renounceable Entitlement Offer - Closing Date		13/04/23	261.56KB	Share
OSX	OSX Strengthens Presence in the Eastern Region of the USA	PRICE SENSITIVE	11/04/23	237.94KB	Share
OSX	Annual General Meeting Date		05/04/23	270.93KB	Share
OSX	Results of General Meeting		31/03/23	238.21KB	Share
OSX	Appendix 4G and Corporate Governance Statement		31/03/23	466.34KB	Share
OSX	Annual Report to Shareholders		31/03/23	950.12KB	Share
OSX	OSX Completes Acquisition to Accelerate Revenue Growth	PRICE SENSITIVE	31/03/23	235.22KB	Share
OSX	Update - Proposed issue of securities - OSX		30/03/23	770.8KB	Share
OSX	Non-Renounceable Entitlement Offer Extension		30/03/23	154.69KB	Share
OSX	OSX Product Approved for Additional Applications in Taiwan		27/03/23	196.75KB	Share
OSX	Prospectus despatched		21/03/23	145.2KB	Share
OSX	Update - Proposed issue of securities - OSX		14/03/23	42.36KB	Share
OSX	Letter to Optionholders		13/03/23	152.5KB	Share
OSX	Letter to Ineligible Shareholders		13/03/23	151.86KB	Share
OSX	Proposed issue of securities - OSX		13/03/23	43.84KB	Share
OSX	Letter to Eligible Shareholders		13/03/23	165.99KB	Share
OSX	Non-Renounceable Entitlement Offer Prospectus	PRICE SENSITIVE	13/03/23	655.44KB	Share
OSX	Non-Renounceable Entitlement Offer	PRICE SENSITIVE	13/03/23	225.78KB	Share
OSX	Notice of General Meeting/Proxy Form		02/03/23	985.97KB	Share
OSX	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	28/02/23	214.39KB	Share
OSX	Osteopore Advisory Panel of Distinguished Industry Leaders		27/02/23	318.18KB	Share
OSX	Investor Presentation		20/02/23	6.22MB	Share
OSX	OSX Enters Orthopaedic Market in Great Britain		14/02/23	233.78KB	Share
OSX	Activities Update Qtr Ending December 2022 and Appendix 4C	PRICE SENSITIVE	31/01/23	619.31KB	Share
OSX	Appointment of Joint Company Secretary		25/01/23	165.42KB	Share
OSX	Integration of Acquired Business for Higher Sales & Margin	PRICE SENSITIVE	23/01/23	269.81KB	Share
OSX	Cleansing Notice		04/01/23	222.94KB	Share
OSX	Application for quotation of securities - OSX		04/01/23	24.96KB	Share
OSX	Notification of cessation of securities - OSX		03/01/23	21.98KB	Share
OSX	Reinstatement to Official Quotation	PRICE SENSITIVE	22/12/22	404.26KB	Share
OSX	Proposed issue of securities - OSX		22/12/22	37.31KB	Share
OSX	Firm Commitments and Non-Binding Proposed Acquisition	PRICE SENSITIVE	22/12/22	258.31KB	Share
OSX	Suspension from Official Quotation	PRICE SENSITIVE	21/12/22	561.44KB	Share
OSX	Trading Halt	PRICE SENSITIVE	19/12/22	639.28KB	Share
OSX	Increased presence and commercial opportunities across SEA	PRICE SENSITIVE	08/12/22	483.33KB	Share
OSX	Activities Update Qtr Ending September 2022 and Appendix 4C	PRICE SENSITIVE	31/10/22	516.48KB	Share
OSX	Ceasing to be a substantial holder		05/10/22	81.33KB	Share
OSX	Change in substantial holding		05/10/22	222.64KB	Share
OSX	Chile Government and University co-fund Osteopore research		28/09/22	279.99KB	Share
OSX	More Osteopore Products Available on Prostheses List		28/09/22	243.9KB	Share
OSX	Half Yearly Report and Accounts	PRICE SENSITIVE	31/08/22	752.78KB	Share
OSX	Change in substantial holding		24/08/22	270.95KB	Share
OSX	Becoming a substantial holder		24/08/22	142.64KB	Share
OSX	Osteopore Moves Closer to China Market Entry	PRICE SENSITIVE	23/08/22	247.2KB	Share
OSX	Investor Presentation		10/08/22	7.76MB	Share
OSX	Osteopore Gains Access to US Federal Healthcare Facilities		03/08/22	242.12KB	Share
OSX	SHG: Clarification regarding collaboration with OSX		02/08/22	528.57KB	Share
OSX	SHG: Collaborative Agreement signed with OSX		01/08/22	758.77KB	Share
OSX	Osteopore to Leverage on AI/VR to Enhance Market Access		01/08/22	424.03KB	Share
OSX	Activities Update Qtr Ending June 2022 and Appendix 4C	PRICE SENSITIVE	25/07/22	776.56KB	Share
OSX	Notification of cessation of securities - OSX		04/07/22	21.56KB	Share
OSX	Change of Director's Interest Notice		01/07/22	279.14KB	Share
OSX	Collaboration With Healthcare Group To Develop New Products		20/06/22	225.32KB	Share
OSX	Change of Director's Interest Notice		15/06/22	199.9KB	Share
OSX	OSX Expands into Africa with Initial Sales to South Africa		14/06/22	207.95KB	Share
OSX	Constitution		01/06/22	674.04KB	Share
OSX	Employee Securities Incentive Plan		01/06/22	221.72KB	Share
OSX	Results of Annual General Meeting		31/05/22	188.96KB	Share
OSX	OSX Enter Oral & Maxillofacial Market in Australia & NZ	PRICE SENSITIVE	10/05/22	407.05KB	Share
OSX	Notice of Annual General Meeting		29/04/22	1.04MB	Share
OSX	Activities Update Qtr Ending March 2022 and Appendix 4C	PRICE SENSITIVE	29/04/22	1.06MB	Share
OSX	Appointment of Chief Operating Officer		28/04/22	214.43KB	Share
OSX	OSX Expands Further into Europe with Initial Sales to Spain		14/04/22	439.67KB	Share
OSX	Annual General Meeting Date		07/04/22	218.14KB	Share
OSX	OSX Expands to Latin America with Initial Sales to Colombia		07/04/22	612.31KB	Share
OSX	Appendix 4G and Corporate Governance Statement		31/03/22	424.27KB	Share
OSX	Annual Report to shareholders		31/03/22	1.7MB	Share
OSX	OSX Commences AI-Powered Design Study for Cranial Implants		14/03/22	253.05KB	Share
OSX	SHG: & CSIRO AI Tool to Optimise Cranial Implant Procedures	PRICE SENSITIVE	14/03/22	341.79KB	Share
OSX	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	28/02/22	256.14KB	Share
OSX	Notification of cessation of securities - OSX		25/02/22	21.54KB	Share
OSX	Appendix 3Y		25/02/22	351.12KB	Share
OSX	Appendix 3Z		15/02/22	227.19KB	Share
OSX	Resignation of Non-Executive Director		15/02/22	213.75KB	Share
OSX	Activities Update Qtr Ending December 2021 and Appendix 4C	PRICE SENSITIVE	28/01/22	503.6KB	Share
OSX	Chief Financial Officer Resignation		18/01/22	199.88KB	Share
OSX	Appendix 3X		29/12/21	225.25KB	Share
OSX	Change to the Board of Directors		29/12/21	233.1KB	Share
OSX	Osteopore secures A$19m clinical-industrial partnership	PRICE SENSITIVE	13/12/21	270.16KB	Share
OSX	Osteopore Receives Approval for Hong Kong Sales		02/12/21	236.86KB	Share
OSX	Investor Presentation		22/11/21	3.71MB	Share

OSX Results of Annual General Meeting
30/05/23		267.26KB	Share
OSX Notification regarding unquoted securities - OSX
25/05/23		27.7KB	Share
OSX Largest South African Medical Insurer provides cover for OSX
16/05/23	PRICE SENSITIVE	278.1KB	Share
OSX Notification regarding unquoted securities - OSX
12/05/23		28.58KB	Share
OSX Change of Registered Office
05/05/23		140.94KB	Share
OSX Change of Director's Interest Notice - TSH
28/04/23		226.02KB	Share
OSX Change of Director's Interest Notice - ML
28/04/23		224.21KB	Share
OSX Notice of Annual General Meeting
28/04/23		615.69KB	Share
OSX Activities Update Qtr Ending March 2023 and Appendix 4C
28/04/23	PRICE SENSITIVE	3.43MB	Share
OSX OSX Successfully transitions to EU Medical Device Regulation
27/04/23	PRICE SENSITIVE	238.93KB	Share
OSX Reinstatement of Security Class to Quotation
26/04/23	PRICE SENSITIVE	412.9KB	Share
OSX Top 20 and Distribution List - Options
26/04/23		17.33KB	Share
OSX Application for quotation of securities - OSX
24/04/23		25.08KB	Share
OSX Application for quotation of securities - OSX
24/04/23		29.48KB	Share
OSX Security Class Suspension from Quotation
24/04/23	PRICE SENSITIVE	416.22KB	Share
OSX Non-Renounceable Entitlement Offer - Results
24/04/23	PRICE SENSITIVE	233.65KB	Share
OSX Osteopore Increases Presence in Singapore Dental Market
14/04/23		247.63KB	Share
OSX Osteopore to Commercialise Innovative Bone Rengeneration Tec
14/04/23		264.89KB	Share
OSX Employee Securities Incentive Plan
13/04/23		370.57KB	Share
OSX Non-Renounceable Entitlement Offer - Closing Date
13/04/23		261.56KB	Share
OSX OSX Strengthens Presence in the Eastern Region of the USA
11/04/23	PRICE SENSITIVE	237.94KB	Share
OSX Annual General Meeting Date
05/04/23		270.93KB	Share
OSX Results of General Meeting
31/03/23		238.21KB	Share
OSX Appendix 4G and Corporate Governance Statement
31/03/23		466.34KB	Share
OSX Annual Report to Shareholders
31/03/23		950.12KB	Share
OSX OSX Completes Acquisition to Accelerate Revenue Growth
31/03/23	PRICE SENSITIVE	235.22KB	Share
OSX Update - Proposed issue of securities - OSX
30/03/23		770.8KB	Share
OSX Non-Renounceable Entitlement Offer Extension
30/03/23		154.69KB	Share
OSX OSX Product Approved for Additional Applications in Taiwan
27/03/23		196.75KB	Share
OSX Prospectus despatched
21/03/23		145.2KB	Share
OSX Update - Proposed issue of securities - OSX
14/03/23		42.36KB	Share
OSX Letter to Optionholders
13/03/23		152.5KB	Share
OSX Letter to Ineligible Shareholders
13/03/23		151.86KB	Share
OSX Proposed issue of securities - OSX
13/03/23		43.84KB	Share
OSX Letter to Eligible Shareholders
13/03/23		165.99KB	Share
OSX Non-Renounceable Entitlement Offer Prospectus
13/03/23	PRICE SENSITIVE	655.44KB	Share
OSX Non-Renounceable Entitlement Offer
13/03/23	PRICE SENSITIVE	225.78KB	Share
OSX Notice of General Meeting/Proxy Form
02/03/23		985.97KB	Share
OSX Appendix 4E Preliminary Final Report
28/02/23	PRICE SENSITIVE	214.39KB	Share
OSX Osteopore Advisory Panel of Distinguished Industry Leaders
27/02/23		318.18KB	Share
OSX Investor Presentation
20/02/23		6.22MB	Share
OSX OSX Enters Orthopaedic Market in Great Britain
14/02/23		233.78KB	Share
OSX Activities Update Qtr Ending December 2022 and Appendix 4C
31/01/23	PRICE SENSITIVE	619.31KB	Share
OSX Appointment of Joint Company Secretary
25/01/23		165.42KB	Share
OSX Integration of Acquired Business for Higher Sales & Margin
23/01/23	PRICE SENSITIVE	269.81KB	Share
OSX Cleansing Notice
04/01/23		222.94KB	Share
OSX Application for quotation of securities - OSX
04/01/23		24.96KB	Share
OSX Notification of cessation of securities - OSX
03/01/23		21.98KB	Share
OSX Reinstatement to Official Quotation
22/12/22	PRICE SENSITIVE	404.26KB	Share
OSX Proposed issue of securities - OSX
22/12/22		37.31KB	Share
OSX Firm Commitments and Non-Binding Proposed Acquisition
22/12/22	PRICE SENSITIVE	258.31KB	Share
OSX Suspension from Official Quotation
21/12/22	PRICE SENSITIVE	561.44KB	Share
OSX Trading Halt
19/12/22	PRICE SENSITIVE	639.28KB	Share
OSX Increased presence and commercial opportunities across SEA
08/12/22	PRICE SENSITIVE	483.33KB	Share
OSX Activities Update Qtr Ending September 2022 and Appendix 4C
31/10/22	PRICE SENSITIVE	516.48KB	Share
OSX Ceasing to be a substantial holder
05/10/22		81.33KB	Share
OSX Change in substantial holding
05/10/22		222.64KB	Share
OSX Chile Government and University co-fund Osteopore research
28/09/22		279.99KB	Share
OSX More Osteopore Products Available on Prostheses List
28/09/22		243.9KB	Share
OSX Half Yearly Report and Accounts
31/08/22	PRICE SENSITIVE	752.78KB	Share
OSX Change in substantial holding
24/08/22		270.95KB	Share
OSX Becoming a substantial holder
24/08/22		142.64KB	Share
OSX Osteopore Moves Closer to China Market Entry
23/08/22	PRICE SENSITIVE	247.2KB	Share
OSX Investor Presentation
10/08/22		7.76MB	Share
OSX Osteopore Gains Access to US Federal Healthcare Facilities
03/08/22		242.12KB	Share
OSX SHG: Clarification regarding collaboration with OSX
02/08/22		528.57KB	Share
OSX SHG: Collaborative Agreement signed with OSX
01/08/22		758.77KB	Share
OSX Osteopore to Leverage on AI/VR to Enhance Market Access
01/08/22		424.03KB	Share
OSX Activities Update Qtr Ending June 2022 and Appendix 4C
25/07/22	PRICE SENSITIVE	776.56KB	Share
OSX Notification of cessation of securities - OSX
04/07/22		21.56KB	Share
OSX Change of Director's Interest Notice
01/07/22		279.14KB	Share
OSX Collaboration With Healthcare Group To Develop New Products
20/06/22		225.32KB	Share
OSX Change of Director's Interest Notice
15/06/22		199.9KB	Share
OSX OSX Expands into Africa with Initial Sales to South Africa
14/06/22		207.95KB	Share
OSX Constitution
01/06/22		674.04KB	Share
OSX Employee Securities Incentive Plan
01/06/22		221.72KB	Share
OSX Results of Annual General Meeting
31/05/22		188.96KB	Share
OSX OSX Enter Oral & Maxillofacial Market in Australia & NZ
10/05/22	PRICE SENSITIVE	407.05KB	Share
OSX Notice of Annual General Meeting
29/04/22		1.04MB	Share
OSX Activities Update Qtr Ending March 2022 and Appendix 4C
29/04/22	PRICE SENSITIVE	1.06MB	Share
OSX Appointment of Chief Operating Officer
28/04/22		214.43KB	Share
OSX OSX Expands Further into Europe with Initial Sales to Spain
14/04/22		439.67KB	Share
OSX Annual General Meeting Date
07/04/22		218.14KB	Share
OSX OSX Expands to Latin America with Initial Sales to Colombia
07/04/22		612.31KB	Share
OSX Appendix 4G and Corporate Governance Statement
31/03/22		424.27KB	Share
OSX Annual Report to shareholders
31/03/22		1.7MB	Share
OSX OSX Commences AI-Powered Design Study for Cranial Implants
14/03/22		253.05KB	Share
OSX SHG: & CSIRO AI Tool to Optimise Cranial Implant Procedures
14/03/22	PRICE SENSITIVE	341.79KB	Share
OSX Appendix 4E Preliminary Final Report
28/02/22	PRICE SENSITIVE	256.14KB	Share
OSX Notification of cessation of securities - OSX
25/02/22		21.54KB	Share
OSX Appendix 3Y
25/02/22		351.12KB	Share
OSX Appendix 3Z
15/02/22		227.19KB	Share
OSX Resignation of Non-Executive Director
15/02/22		213.75KB	Share
OSX Activities Update Qtr Ending December 2021 and Appendix 4C
28/01/22	PRICE SENSITIVE	503.6KB	Share
OSX Chief Financial Officer Resignation
18/01/22		199.88KB	Share
OSX Appendix 3X
29/12/21		225.25KB	Share
OSX Change to the Board of Directors
29/12/21		233.1KB	Share
OSX Osteopore secures A$19m clinical-industrial partnership
13/12/21	PRICE SENSITIVE	270.16KB	Share
OSX Osteopore Receives Approval for Hong Kong Sales
02/12/21		236.86KB	Share
OSX Investor Presentation
22/11/21		3.71MB	Share

REFRESH

First 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.0¢		Change -0.001(9.09%)		Mkt cap ! $2.372M

Open	High	Low	Value	Volume
1.1¢	1.1¢	0.9¢	$63.62K	6.353M

Buyers (Bids)

No.	Vol.	Price($)
20	2845004	0.9¢

Sellers (Offers)

Price($)	Vol.	No.
1.0¢	382386	4

View Market Depth

No.	Vol.	Price($)
20	2845004	0.009
11	3643610	0.008
5	1550857	0.007
6	2950000	0.006
6	2114000	0.005

Price($)	Vol.	No.
0.010	382386	4
0.011	5284895	10
0.012	4353451	11
0.013	1859838	9
0.014	2172726	7

Last trade - 15.45pm 11/08/2025 (20 minute delay)


Last 1.0¢		Change -0.001 ( 9.09 %)
Open	High	Low	Volume
1.0¢	1.1¢	1.0¢	5142824
Last updated 15.11pm 11/08/2025 ?

OSX (ASX) Chart

OSTEOPORE LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories